Evidence map›Paper›PMID 27493705›Full record

ArticleOxidative medicine and cellular longevity2016

Antioxidant and Antihyperlipidemic Effects of Campomanesia adamantium O. Berg Root.

Priscilla Pereira de Toledo Espindola, Paola Dos Santos da Rocha, Carlos Alexandre Carollo, Wanderlei Onofre Schmitz, Zefa Valdivina Pereira, Maria do Carmo Vieira, Edson Lucas Dos Santos, Kely de Picoli Souza

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
11.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Lipid-Lowering and Anti-Inflammatory Effects ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. Chemical Composition, Antimicrobial Activity, and Antioxidant Activity ofOxidative medicine and cellular longevity · 2019
    Article
  7. Review
  8. Article
  9. Article
  10. Therapeutic Potential of Brazilian CerradoMolecules (Basel, Switzerland) · 2018
    Review
  11. Article
  12. Effect of Polyphenols FromFrontiers in pharmacology · 2018
    Article
  13. Antiulcer Activity and Potential Mechanism of Action of the Leaves ofOxidative medicine and cellular longevity · 2018
    Article
  14. Article
  15. Article
  16. Hypolipidemic effect of β-caryophyllene to treat hyperlipidemic rats.Naunyn-Schmiedeberg's archives of pharmacology · 2017
    Article
  17. Leaf and Root Extracts fromFrontiers in pharmacology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Priscilla Pereira de Toledo EspindolaFederal University of Grande Dourados, Rodovia Dourados-Itahum, Km 12, 79804-970 Dourados, MS, Brazil.
Paola Dos Santos da RochaFederal University of Grande Dourados, Rodovia Dourados-Itahum, Km 12, 79804-970 Dourados, MS, Brazil.ORCID 0000-0003-1019-1202
Carlos Alexandre CarolloFederal University of Mato Grosso do Sul, Cidade Universitária, s/n, 79070-900 Campo Grande, MS, Brazil.ORCID 0000-0003-1231-9441
Wanderlei Onofre SchmitzFederal University of Grande Dourados, Rodovia Dourados-Itahum, Km 12, 79804-970 Dourados, MS, Brazil.ORCID 0000-0001-8079-3431
Zefa Valdivina PereiraFederal University of Grande Dourados, Rodovia Dourados-Itahum, Km 12, 79804-970 Dourados, MS, Brazil.ORCID 0000-0003-3344-3249
Maria do Carmo VieiraFederal University of Grande Dourados, Rodovia Dourados-Itahum, Km 12, 79804-970 Dourados, MS, Brazil.ORCID 0000-0001-7047-3848
Edson Lucas Dos SantosFederal University of Grande Dourados, Rodovia Dourados-Itahum, Km 12, 79804-970 Dourados, MS, Brazil.ORCID 0000-0002-6557-7914
Kely de Picoli SouzaFederal University of Grande Dourados, Rodovia Dourados-Itahum, Km 12, 79804-970 Dourados, MS, Brazil.ORCID 0000-0001-5764-2125
Universidade Federal da Grande Dourados · BRUniversidade Federal de Mato Grosso do Sul · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Campomanesia adamantium O. Berg, popularly known as guavira, has been used in Brazilian traditional medicine for reduction of serum lipid. The present study was carried out to investigate the antioxidant and antihyperlipidemic effects of Campomanesia adamantium root aqueous extract (ExCA). Phenolic compounds were quantified in the ExCA and gallic and ellagic acids were identified by HPLC. ExCA showed efficiency in 2,2-diphenyl-1-picrylhydrazyl free radical scavenging, with IC50 similar to butylhydroxytoluene control, and protected the erythrocytes against lipid peroxidation induced by 2,2'-azobis(2-methylpropionamidine) dihydrochloride, reducing generated malondialdehyde. Hyperlipidemic Wistar rats treated daily by gavage during eight weeks with ExCA (200 mg/kg of body weight) showed reduced serum level of total cholesterol and triglycerides, similar to normolipidemic rats and hyperlipidemic rats treated with simvastatin (30 mg/kg of body weight) and ciprofibrate (2 mg/kg of body weight). Moreover, the treatment with ExCA also decreased malondialdehyde serum level in the hyperlipidemic rats. The body weight and organ mass were unmodified by ExCA in hyperlipidemic rats, except an increase of liver mass; however, the hepatic enzymes, alanine aminotransferase and aspartate aminotransferase, were unchanged. Together, these results confirm the potential value of Campomanesia adamantium root for lowering lipid peroxidation and lipid serum level, improving risk factors for cardiometabolic diseases development.

Indexed as

Alanine TransaminaseAnimalsAntioxidantsAspartate AminotransferasesBiphenyl CompoundsChromatography, High Pressure LiquidFree Radical ScavengersHemolysisHumansHypolipidemic AgentsInhibitory Concentration 50LipidsMalondialdehydeMyrtaceaePicratesPlant Extracts1,1-diphenyl-2-picrylhydrazylAlanine TransaminaseAntioxidantsAspartate AminotransferasesBiphenyl CompoundsFree Radical ScavengersHypolipidemic AgentsLipidsMalondialdehydePicratesPlant Extracts

Identifiers

PMID27493705
PMCPMC4963595
OpenAlexW2485269456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.